Oculis Holding AG

# Oculis Holding AG

Incorporated in Switzerland and listed on Nasdaq, Oculis Holding AG operates in the pharmaceutical preparations sector with a focus on ophthalmology. The company develops and commercializes pharmaceutical products targeting eye disease treatment, positioning itself within the specialized pharmaceuticals market.

The company's business model centers on the development, manufacturing, and distribution of ophthalmic medications. Oculis has built its portfolio around treatments addressing conditions affecting vision and ocular health, with operations spanning research, regulatory approval, and market commercialization across multiple geographies.

Specific details regarding employee headcount, annual revenue scale, and precise geographic distribution of revenues are not uniformly disclosed in publicly available sources. The company maintains operations consistent with a mid-sized specialty pharmaceutical enterprise, with commercial activities extending across major pharmaceutical markets. Further information regarding business segment breakdown and detailed operational metrics can be found in the company's regulatory filings and investor relations materials.